Michelle McMullen1, Katherine Karakasis1, Robert Rottapel2,3,4,5,6, Amit M Oza7. 1. Division of Medical Oncology & Hematology, Bras Family Drug Development Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. 2. Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. 3. Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada. 4. Department of Medicine, University of Toronto, Toronto, Ontario, Canada. 5. Department of Immunology, University of Toronto, Toronto, Ontario, Canada. 6. Division of Rheumatology, St. Michael's Hospital, Toronto, Ontario, Canada. 7. Division of Medical Oncology & Hematology, Bras Family Drug Development Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. amit.oza@uhn.ca.
Authors: Antonino Bruno; Douglas M Noonan; Roberto Valli; Giovanni Porta; Roberto Taramelli; Lorenzo Mortara; Francesco Acquati Journal: Int J Mol Sci Date: 2022-08-13 Impact factor: 6.208